1,5-二取代四唑的四组分反应抗癌评价(ua - 4cr)

C. Pandit, P. Dholaria, K. Kapadiya
{"title":"1,5-二取代四唑的四组分反应抗癌评价(ua - 4cr)","authors":"C. Pandit, P. Dholaria, K. Kapadiya","doi":"10.14233/ajomc.2019.ajomc-p204","DOIUrl":null,"url":null,"abstract":"Azide isocyanide-based multicomponent reactions allow the formation of relatively complex molecules through a one-pot synthesis. The proposed reactions have been coupled of four classes of compounds including 3-phenoxybenzaldehyde, various aromatic amines, TMS-N3 and tertiary butylisocyanide, which is known as Ugi-azide four-component reactions (UA-4CRs). It generated a diverse class of 1,5-disubstituted tetrazoles which are an important drug-like scaffold known for their ability to mimic the carcinogenic conformers used in medicinal chemistry. This work presents a concise, novel, general strategy to access a surplus of new heterocyclic scaffolds through the Ugi-azide reaction. Frequency in anticancer drug design can be partly attributed to their being extremely common in nature and there are multiple metabolic pathways and cellular processes within cancer pathology that can be susceptible to heterocycles-based drugs. The anticancer screening of derived molecules were carried out using one dose response study using NCI-60 cell-lines and found most active in breast cancer cell-lines","PeriodicalId":8846,"journal":{"name":"Asian Journal of Organic & Medicinal Chemistry","volume":"109 5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anticancer Evaluation of 1,5-Disubstituted Tetrazoles using\\nUgi-Azide Four-Component Reactions (UA-4CRs)\",\"authors\":\"C. Pandit, P. Dholaria, K. Kapadiya\",\"doi\":\"10.14233/ajomc.2019.ajomc-p204\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Azide isocyanide-based multicomponent reactions allow the formation of relatively complex molecules through a one-pot synthesis. The proposed reactions have been coupled of four classes of compounds including 3-phenoxybenzaldehyde, various aromatic amines, TMS-N3 and tertiary butylisocyanide, which is known as Ugi-azide four-component reactions (UA-4CRs). It generated a diverse class of 1,5-disubstituted tetrazoles which are an important drug-like scaffold known for their ability to mimic the carcinogenic conformers used in medicinal chemistry. This work presents a concise, novel, general strategy to access a surplus of new heterocyclic scaffolds through the Ugi-azide reaction. Frequency in anticancer drug design can be partly attributed to their being extremely common in nature and there are multiple metabolic pathways and cellular processes within cancer pathology that can be susceptible to heterocycles-based drugs. The anticancer screening of derived molecules were carried out using one dose response study using NCI-60 cell-lines and found most active in breast cancer cell-lines\",\"PeriodicalId\":8846,\"journal\":{\"name\":\"Asian Journal of Organic & Medicinal Chemistry\",\"volume\":\"109 5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Organic & Medicinal Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14233/ajomc.2019.ajomc-p204\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Organic & Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14233/ajomc.2019.ajomc-p204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

叠氮化物异氰化物为基础的多组分反应允许形成相对复杂的分子通过一个锅合成。该反应由4类化合物(3-苯氧苯甲醛、各种芳香胺、TMS-N3和叔丁基异氰酸酯)偶联而成,称为脲叠氮化物四组分反应(UA-4CRs)。它产生了不同种类的1,5-二取代四唑,这是一种重要的药物样支架,以其模仿药物化学中使用的致癌构象的能力而闻名。这项工作提出了一种简洁、新颖、通用的策略,通过ugi叠氮化物反应获得剩余的新杂环支架。抗癌药物设计的频率可以部分归因于它们在自然界中非常普遍,并且在癌症病理中存在多种代谢途径和细胞过程,这些途径和细胞过程可能对杂环类药物敏感。利用NCI-60细胞株进行单剂量反应研究,对衍生分子进行抗癌筛选,发现其在乳腺癌细胞株中最具活性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Anticancer Evaluation of 1,5-Disubstituted Tetrazoles using Ugi-Azide Four-Component Reactions (UA-4CRs)
Azide isocyanide-based multicomponent reactions allow the formation of relatively complex molecules through a one-pot synthesis. The proposed reactions have been coupled of four classes of compounds including 3-phenoxybenzaldehyde, various aromatic amines, TMS-N3 and tertiary butylisocyanide, which is known as Ugi-azide four-component reactions (UA-4CRs). It generated a diverse class of 1,5-disubstituted tetrazoles which are an important drug-like scaffold known for their ability to mimic the carcinogenic conformers used in medicinal chemistry. This work presents a concise, novel, general strategy to access a surplus of new heterocyclic scaffolds through the Ugi-azide reaction. Frequency in anticancer drug design can be partly attributed to their being extremely common in nature and there are multiple metabolic pathways and cellular processes within cancer pathology that can be susceptible to heterocycles-based drugs. The anticancer screening of derived molecules were carried out using one dose response study using NCI-60 cell-lines and found most active in breast cancer cell-lines
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信